Skip to content

Beetroot Supplementation in Women Enjoying Exercise Together

Beetroot Supplementation in Women Enjoying Exercise Together

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04370756
Acronym
BEE SWEET
Enrollment
30
Registered
2020-05-01
Start date
2020-01-30
Completion date
2023-05-26
Last updated
2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Obesity, Postmenopause

Keywords

Beetroot juice, Postmenopause, Exercise training, Endothelial function

Brief summary

This study seeks to determine the feasibility of an exercise training progression with the consumption of beetroot juice prior to exercise in postmenopausal women. Results from this investigation will be used to determine preliminary effect sizes for exercise training only (control) and exercise training + beetroot juice (EX+BR) to inform the direction of larger randomized clinical trials on pre-post changes in measures of cardiovascular health and endothelial function.

Detailed description

An increasing body of evidence has supported acute benefits of beetroot juice including lowered blood pressure and greater muscle oxygenation during exercise. Thus, consumption of beetroot juice prior to exercise may alter the perceptual difficulty for a given exercise bout -- possibly resulting in an individual exercising at a greater intensity (without the commensurate increase in discomfort). The investigators propose that repeated exposure to a relatively greater exercise stimulus (via beetroot juice) may elicit more robust cardio-metabolic adaptations compared to exercise training alone (i.e., without beetroot juice). Possible findings could inform a larger randomized clinical trial to determine if pre-exercise beetroot juice supplementation is an effective strategy to promote health related benefits. The investigators will examine the effects of pre-exercise beetroot juice coupled with 8 weeks of supervised exercise training among post-menopausal (75 and younger) women. Qualified individuals will be required to complete an initial screening visit as well as three baseline visits (Visits 1-2). Participants will undergo a series of tests including: dual-energy X-ray absorptiometry scan, bioelectrical impedance analysis, exhaled fraction of nitric oxide, health-related questionnaires, and pulse wave velocity. Participants will also be asked to perform leg muscle function and walking tests. Following the completion of Visits 1-2, participants will attend supervised exercise training sessions 3x/week for 8 weeks. Within 2-6 days from the last exercise training session, participants will repeat the same measurement procedures. The primary objective involves elements of feasibility (e.g., recruitment, retention, adherence, and adverse event) and to generate preliminary effect sizes for 8 weeks of exercise training for two groups: control and EX+BR. Secondary objectives involve preliminary effect sizes for pre-post changes in distance covered during the 6-minute walk test, changes in endothelial-dependent vasodilation, and biomarkers of cardiovascular health.

Interventions

DIETARY_SUPPLEMENTBeetroot Juice

Participants randomly assigned to the EX + BR group will consume 140 mL beetroot juice containing approximately 12 mmol of nitrate 3 hours prior to the supervised exercise training component.

OTHERExercise Training

Participants will perform 8 weeks of supervised exercise training at a frequency of 3x per week.

Sponsors

IU Health University Hospital
CollaboratorUNKNOWN
Indiana CTSI Clinical Research Center
CollaboratorUNKNOWN
Bloomington Crossfit
CollaboratorUNKNOWN
Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Group allocation will be determined at random using a computer-based number in blocks of 2 to ensure equal between-group distribution (i.e. n = 2 Ex only; n = 2 BR+EX). Each number will be kept in a sealed envelope until completion of Visits 1-2.

Intervention model description

Participants will be enrolled in small (n = 4) cohorts or waves to facilitate social support and adherence to the supervised exercise training sessions. We anticipate having 9 waves to successfully reach our target n. This assumes that each wave will have 4 participants, hence, 4 participants x 9 waves = 36 total participants. Subsequently, participants will be randomly selected to: 1) control (EX only) or 2) EX + Beetroot Juice.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Post-menopausal women (self-report) * Between the ages of 18-75 years (confirmed by birth date listed on participant's driver license at screening visit) * Physician's clearance for study participation (required prior to baseline testing) * English-speaking * Body mass index between 25.0 to 39.9 kg/m\^2 (measured on-site at screening visit) * Able to ambulate without assistance

Exclusion criteria

* Unable to provide informed consent * 18-75 of age (confirmed by birth date listed on participant's driver license at screening visit) * Body mass index \< 25.0 or \>39.9 kg/m\^2 (measured on-site at screening visit) * Greater than stage II hypertension (i.e. \>159/99 mm Hg) * Current smoker (self-report) * Currently pregnant, lactating, or trying to become pregnant (self-report) * Habitually exercise training \>= 3 times per week (self-report) * Significant orthopedic limitations or other contraindications to strenuous exercise * Live or work \>50 miles from Bloomington study site or do not have transportation to the study site * Anticipate elective surgery during the study period * Plan to move residence or travel out of the local area during the study period * History of major metabolic disease (e.g. Type I diabetes, Type II diabetes, thyroid disorders) * Current use of anti-coagulants (e.g. Coumadin or Warfarin) * Current use of prescription medications that affect heart rate or blood vessel dilation (e.g. phosphodiesterase-5 inhibitors, proton pump inhibitors, systemic adrenergic blockers, nitrates, calcium channel blockers, hormone replacement therapy) (self-report and confirmed on-site at screening visit) * Psychological or social characteristic that would interfere with their ability to fully participate in the study (i.e. taking longer than allowed time to complete cognitive assessments)

Design outcomes

Primary

MeasureTime frameDescription
Retention rate8 weeksThe number of randomized participants who complete at least 17 (out of 24 possible) exercise training sessions.
Adherence to dietary nitrate intervention8 weeksBreath analysis of fractional exhaled nitric oxide concentrations.
Perceived difficulty of training sessions8 weeksParticipants will report the perceived exertion at the end of exercise sessions using the Borg category ratio-10 scale that ranges from 0 no exertion to 10 maximal exertion.
Recruitment rate24 monthsThe number of eligible participants randomized per months of recruitment time.
Adherence to exercise training intervention8 weeksThe percent of exercise sessions attended out of the 24 possible sessions.

Secondary

MeasureTime frameDescription
Soluble endothelial microparticlesBaseline, post-interventionBlood samples will be analyzed for adhesion molecules (sICAM-1, sVCAM-1, sE-selectin).
Distance covered during a six-minute walk testBaseline, post-interventionParticipants will be asked to walk as far as possible at a preferred speed for six minutes according to ATS standards. Distance covered will be measured in meters.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026